The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases

Endocrine Reviews

Volumn 33, Issue 4, 2012, Pages 526-546

  Prudente, Sabrina ^a   Sesti, Giorgio ^c   Pandolfi, Assunta ^d   Andreozzi, Francesco ^c   Consoli, Agostino ^d   Trischitta, Vincenzo ^a,b,e  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Research Unit of Diabetes and Endocrine Diseases   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOTRANSFERASE; TRIBBLE HOMOLOG 1; TRIBBLE HOMOLOG 2; TRIBBLE HOMOLOG 3; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL SURVIVAL; DISEASE ASSOCIATION; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME STRUCTURE; GENETIC POLYMORPHISM; GLUCOSE HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CARDIOVASCULAR DISEASES; CELL CYCLE PROTEINS; GLUCOSE; GLUCOSE METABOLISM DISORDERS; HOMEOSTASIS; HUMANS; INSULIN; MOLECULAR STRUCTURE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REPRESSOR PROTEINS;

EID: 84864025989     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2011-1042     Document Type: Article

References (102)

1. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. 2000 Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23:171-175
2. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. 1990 Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915
3. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. 1993 Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988- 1992
4. Reaven GM. 1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
5. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. 1987 Insulin resistance in essential hypertension. N Engl J Med 317:350-357
6. Muniyappa R, Montagnani M, Koh KK, Quon MJ. 2007 Cardiovascular actions of insulin. Endocr Rev 28:463-491
7. Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L. 2002 Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 19:470-475
8. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. 2005 Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072
9. WannametheeSG, ShaperAG,Lennon L, MorrisRW. 2005 Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644-2650
10. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. 2011 Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219-231
11. Stefan N, Staiger H, Häring HU. 2011 Dissociation between fatty liver and insulin resistance: the role of adipose triacylglycerol lipase. Diabetologia 54:7-9
12. Ristow M. 2004 Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl) 82:510-529
13. Renehan A, Smith U, Kirkman MS. 2010 Linking diabetes and cancer: a consensus on complexity. Lancet 375:2201- 2202
14. Sesti G, FedericiM,HribalML,Lauro D, Sbraccia P, Lauro R. 2001 Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15:2099- 2111
15. Cohen P. 2006 The twentieth century struggle to decipher insulin signalling. Nat Rev Mol Cell Biol 7:867-873
16. TaniguchiCM,Emanuelli B, KahnCR. 2006 Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85-96
17. Yu Q, Gao F, Ma XL. 2011 Insulin says NO to cardiovascular disease. Cardiovasc Res 89:516-524
18. Elghazi L, Bernal-Mizrachi E. 2009 Akt and PTEN: β-cell mass and pancreas plasticity. Trends Endocrinol Metab 20:243-251
19. Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L. 2008 The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev 29:62-75
20. Du K, Herzig S, Kulkarni RN, Montminy M. 2003 TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300:1574-1577
21. Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. 2000 Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J Biol Chem 275: 4283-4289
22. D'Alessandris C, Lauro R, Presta I, SestiG. 2007 C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia 50:840-849
23. Schenk S, Saberi M, Olefsky JM. 2008 Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118:2992-3002
24. Andreozzi F, Laratta E, Procopio C, Hribal ML, Sciacqua A, Perticone M, Miele C, Perticone F, Sesti G. 2007 Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells. Mol Cell Biol 27:2372-2383
25. Clément S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S. 2001 The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409:92-97
26. GaoT, Furnari F, NewtonAC. 2005 PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18:13-24
27. Andreozzi F, Procopio C, Greco A, Mannino GC, Miele C, Raciti GA, Iadicicco C, Beguinot F, Pontiroli AE, Hribal ML, Folli F, Sesti G. 2011 Increased levels of the Aktspecific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Diabetologia 54:1879-1887
28. Saltiel AR. 2003 Putting the brakes on insulin signaling. N Engl J Med 349:2560-2562
29. Prudente S, Scarpelli D, Chandalia M, Zhang YY, Morini E, Del Guerra S, Perticone F, Li R, Powers C, Andreozzi F, Marchetti P, Dallapiccola B, Abate N, Doria A, Sesti G, Trischitta V, 2009 The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab 94:190-196
30. Mata J, Curado S, Ephrussi A, Rørth P. 2000 Tribbles coordinates mitosis and morphogenesis in Drosophila by regulating string/CDC25 proteolysis. Cell 101:511-522
31. Hanks SK, Hunter T, 1995 Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9:576-596
32. Ord D, Ord. T 2005 Characterization of human NIPK (TRB3, SKIP3) gene activation in stressful conditions. Biochem Biophys Res Commun 330:210-218
33. Hughes TA. 2006 Regulation of gene expression by alternative untranslated regions. Trends Genet 22:119-122
34. Yokoyama T, Nakamura T. 2011 Tribbles in disease: signaling pathways important for cellular function and neoplastic transformation. Cancer Sci 102:1115-1122
35. Hegedus Z, Czibula A, Kiss-Toth E. 2007 Tribbles: a family of kinase-like proteins with potent signalling regulatory function. Cell Signal 19:238-250
36. Matsushima R, Harada N, Webster NJ, Tsutsumi YM, Nakaya Y. 2006 Effect of TRB3 on insulin and nutrientstimulated hepatic p70 S6 kinase activity. J Biol Chem 281: 29719-29729
37. Liu J, Wu X, Franklin JL, Messina JL, Hill HS, Moellering DR,WaltonRG,MartinM,GarveyWT. 2010Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance.AmJ Physiol Endocrinol Metab 298:E565-E576
38. Koh HJ, Arnolds DE, Fujii N, Tran TT, Rogers MJ, Jessen N, Li Y, Liew CW, Ho RC, Hirshman MF, Kulkarni RN, Kahn CR, Goodyear LJ. 2006 Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 26:8217-8227
39. Cheng KK, IglesiasMA,LamKS,WangY, Sweeney G,Zhu W, Vanhoutte PM, Kraegen EW, Xu A. 2009 APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab 9:417-427
40. Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa V, Dempsey C, Caunt JC, Oxley KM, Wyllie DH, Polgar T, Harte M, O'neill LA, Qwarnstrom EE, Dower SK. 2004 Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 279:42703-42708
41. Bi XP, Tan HW, Xing SS, Wang ZH, Tang MX, Zhang Y, Zhang W. 2008 Overexpression of TRB3 gene in adipose tissue of rats with high fructose-induced metabolic syndrome. Endocr J 55:747-752
42. Wang YG, Shi M, Wang T, Shi T, Wei J, Wang N, Chen XM. 2009 Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease. World J Gastroenterol 15:2329-2335
43. Okamoto H, Latres E, Liu R, Thabet K, Murphy A, Valenzeula D, Yancopoulos GD, Stitt TN, Glass DJ, Sleeman MW. 2007 Genetic deletion of Trb3, the mammalian Drosophila tribbles homolog, displays normal hepatic insulin signaling and glucose homeostasis. Diabetes 56:1350- 1356
44. Weismann D, Erion DM, Ignatova-Todorava I, Nagai Y, Stark R, Hsiao JJ, Flannery C, Birkenfeld AL,MayT, Kahn M, Zhang D, Yu XX, Murray SF, Bhanot S, Monia BP, Cline GW, Shulman GI, Samuel VT. 2011 Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in a rat model of insulin resistance. Diabetologia 54:935-944
45. Matos A, Ropelle ER, Pauli JR, Frederico MJ, de Pinho RA, Velloso LA, De Souza CT. 2010 Acute exercise reverses TRB3 expression in the skeletal muscle and ameliorates whole body insulin sensitivity in diabetic mice. Acta Physiol (Oxf) 198:61-69
46. Lima AF, Ropelle ER, Pauli JR, Cintra DE, Frederico MJ, Pinho RA, Velloso LA, De Souza CT. 2009 Acute exercise reduces insulin resistance-induced TRB3 expression and amelioration of the hepatic production of glucose in the liver of diabetic mice. J Cell Physiol 221:92-97
47. Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M. 2004 PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nat Med 10:530-534
48. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. 2003 β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
49. Robertson RP. 2009 β-Cell deterioration during diabetes: what's in the gun? Trends Endocrinol Metab 20:388-393
50. Humphrey RK, Newcomb CJ, Yu SM, Hao E, Yu D, Krajewski S, Du K, Jhala US. 2010 Mixed lineage kinase-3 stabilizes and functionally cooperates with TRIBBLES-3 to compromise mitochondrial integrity in cytokine-induced death of pancreaticβ-cells. J BiolChem285:22426-22436
51. Bezy O, Vernochet C, Gesta S, Farmer SR, Kahn CR 2007 TRB3 blocks adipocyte differentiation through the inhibition of C/EBPβ transcriptional activity. Mol Cell Biol 27: 6818-6831
52. Qi L, Heredia JE, Altarejos JY, Screaton R, Goebel N, Niessen S, Macleod IX, Liew CW, Kulkarni RN, Bain J, Newgard C, Nelson M, Evans RM, Yates J, MontminyM. 2006 TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science 312:1763-1766
53. Naiki T, Saijou E, Miyaoka Y, Sekine K, Miyajima A. 2007 TRB2, a mouse Tribbles ortholog, suppresses adipocyte differentiation by inhibitingAKTand C/EBPβ. J BiolChem 282:24075-24082
54. Takahashi Y, Ohoka N, Hayashi H, Sato R. 2008 TRB3 suppresses adipocyte differentiation by negatively regulating PPARγ transcriptional activity. J Lipid Res 49:880- 892
55. Burkhardt R, Toh SA, Lagor WR, Birkeland A, Levin M, Li X, Robblee M, Fedorov VD, Yamamoto M, Satoh T, Akira S, Kathiresan S, Breslow JL, Rader DJ. 2010 Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. J Clin Invest 120:4410-4414
56. Kato S,DuK. 2007 TRB3modulatesC2C12differentiation by interfering with Akt activation. Biochem Biophys Res Commum 353:933-938
57. Hotamisligil GS. 2010 Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917
58. Mayumi-Matsuda K, Kojima S, Suzuki H, Sakata T. 1999 Identification of a novel kinase-like gene induced during neuronal cell death. Biochem Biophys Res Commun 258: 260-264
59. Ord D, Ord T. 2003 Mouse NIPK interacts with ATF4 and affects its transcriptional activity. Exp Cell Res 286:308-320
60. Wu M, Xu LG, Zhai Z, Shu HB. 2003 SINK is a p65-interacting negative regulator of NF-?B-dependent transcription. J Biol Chem 278:27072-27079
61. He L, Marecki JC, Serrero G, Simmen FA, Ronis MJ, BadgerTM. 2007 Dose-dependent effects of alcohol on insulin signaling: partial explanation for biphasic alcohol impact on human health. Mol Endocrinol 21:2541-2550
62. Hartley T, Siva M, Lai E, Teodoro T, Zhang L, Volchuk A. 2010 A Endoplasmic reticulum stress response in an INS-1 pancreatic β-cell line with inducible expression of a folding-deficient proinsulin. BMC Cell Biol 11:59
63. Nicoletti-Carvalho JE, Nogueira TC, Gorjão R, Bromati CR, Yamanaka TS, Boschero AC, Velloso LA, Curi R, Anhê GF, Bordin S. 2010 UPR-mediated TRIB3 expression correlates with reduced AKT phosphorylation and inability of interleukin 6 to overcome palmitate-induced apoptosis in RINm5F cells. J Endocrinol 206:183-193
64. Yacoub Wasef SZ, Robinson KA, Berkaw MN, Buse MG. 2006 Glucose, dexamethasone, and the unfolded protein response regulate TRB3 mRNA expression in 3T3-L1 adipocytes and L6 myotubes.AmJ Physiol Endocrinol Metab 291:E1274-E1280
65. Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H. 2005 TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 24:1243-1255
66. Jousse C, Deval C, Maurin AC, Parry L, Chérasse Y, Chaveroux C, Lefloch R, Lenormand P, Bruhat A, Fafournoux P. 2007 TRB3 inhibits the transcriptional activation of stress-regulated genes by a negative feedback on the ATF4 pathway. J Biol Chem 282:15851-15861
67. Avery J, Etzion S, DeBosch BJ, Jin X, Lupu TS, Beitinjaneh B, Grand J, Kovacs A, Sambandam N, Muslin AJ. 2010 TRB3 function in cardiac endoplasmic reticulum stress. Circ Res 106:1516-1523
68. Eizirik DL, Cardozo AK, Cnop M. 2008 The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42-61
69. Bromati CR, Lellis-Santos C, Yamanaka TS, Nogueira TC, Leonelli M, Caperuto LC, Gorjão R, Leite AR, Anhê GF, Bordin S. 2011 UPR induces transient burst of apoptosis in islets of early lactating rats through reduced AKT phosphorylation viaATF4/CHOPstimulation ofTRB3expression. Am J Physiol Regul Integr Comp Physiol 300: R92-R100
70. Qian B, Wang H, Men X, Zhang W, Cai H, Xu S, Xu Y, Ye L, Wollheim CB, Lou J. 2008 TRIB3 [corrected] is implicated in glucotoxicity- and endoplasmic reticulumstress-induced β-cell apoptosis. J Endocrinol [Errata (2009) 203:399, 200:243] 199:407-416
71. Liew CW, Bochenski J, Kawamori D, Hu J, Leech CA, Wanic K, Malecki M, Warram JH, Qi L, Krolewski AS, Kulkarni RN. 2010 The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse β-cells. J Clin Invest 120:2876- 2888
72. Ding J, Kato S, Du K. 2008 PI3K activates negative and positive signals to regulate TRB3 expression in hepatic cells. Exp Cell Res 314:1566-1574
73. Du K, Ding J. 2009 Insulin regulates TRB3 and other stressresponsive gene expression through induction of C/EBPβ. Mol Endocrinol 23:475-485
74. Matsumoto M, Han S, Kitamura T, Accili D. 2006 Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116: 2464-2472
75. Oberkofler H, Pfeifenberger A, Soyal S, Felder T, Hahne P, Miller K, Krempler F, Patsch W. 2010 Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans. Diabetologia 53:1971-1975
76. Prudente S, Hribal ML, Flex E, Turchi F, Morini E, De Cosmo S, Bacci S, Tassi V, Cardellini M, Lauro R, Sesti G, Dallapiccola B, Trischitta V. 2005 The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 54:2807-2811
77. Andreozzi F, Formoso G, Prudente S, Hribal ML, Pandolfi A, Bellacchio E, Di Silvestre S, Trischitta V, Consoli A, Sesti G. 2008 TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. Arterioscler Thromb Vasc Biol 28:1355-1360
78. Federici M, Pandolfi A, De Filippis EA, Pellegrini G, Menghini R, Lauro D, Cardellini M, Romano M, Sesti G, Lauro R, Consoli A. 2004 G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation 109:399-405
79. Bacci S, Di Paola R, Menzaghi C, Di Fulvio P, Di Silvestre S, Pellegrini F, Baratta R, Marucci A, Mastroianno S, Fini G, Formoso G, Consoli A, Perticone F, Frittitta L, Pandolfi A, TrischittaV. 2009 ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol 29:1678-1683
80. Rask-Madsen C, Li Q, Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, Clermont A, Geraldes P, Dall'Osso C, Wagers AJ, Huang PL, Rekhter M, Scalia R, Kahn CR, King GL. 2010 Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 11:379-389
81. Formoso G, Di Tomo P, Andreozzi F, Succurro E, Di Silvestre S, Prudente S, Perticone F, Trischitta V, Sesti G, Pandolfi A, Consoli A. 2011 The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. Cardiovasc Res 89:184-192
82. Porzio O, FedericiM,HribalML,Lauro D, Accili D, Lauro R, Borboni P, Sesti G. 1999 The Gly9723Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic β-cells. J Clin Invest 104:357-364
83. Federici M, Hribal ML, Ranalli M, Marselli L, Porzio O, Lauro D, Borboni P, Lauro R, Marchetti P, Melino G, Sesti G. 2001 The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. FASEB J 15:22-24
84. Marchetti P, Lupi R, Federici M, Marselli L, Masini M, Boggi U, Del Guerra S, Patanè G, Piro S, Anello M, Bergamini E, Purrello F, Lauro R, Mosca F, Sesti G, Del Prato S. 2002 Insulin secretory function is impaired in isolated human islets carrying the Gly(972)3Arg IRS-1 polymorphism. Diabetes 51:1419-1424
85. Di Paola R, Caporarello N, Marucci A, Dimatteo C, Iadicicco C, Del Guerra S, Prudente S, Sudano D, Miele C, Parrino C, Piro S, Beguinot F, Marchetti P, Trischitta V, Frittitta L. 2011 ENPP1 affects insulin action and secretion: evidences from in vitro studies. PloS One 6:e19462
86. Kulkarni RN, Brü ning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. 1999 Tissue-specific knockout of the insulin receptor in pancreatic β-cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96: 329-339
87. Prudente S, Baratta R, Andreozzi F, Morini E, Farina MG, Nigro A, Copetti M, Pellegrini F, Succurro E, Di Pietrantonio L, Brufani C, Barbetti F, Dallapiccola B, Sesti G, Trischitta V, Frittitta L .2010 TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion. Diabetologia 53:1354- 1361
88. Gong HP, Wang ZH, Jiang H, Fang NN, Li JS, Shang YY, Zhang Y, Zhong M, Zhang W. 2009 TRIB3 functional Q84R polymorphism is a risk factor for metabolic syndrome and carotid atherosclerosis. Diabetes Care 32: 1311-1313
89. Shi Z, Liu J, Guo Q, Ma X, Shen L, Xu S, Gao H, Yuan X, Zhang J. 2009 Association of TRB3 gene Q84R polymorphism with type 2 diabetes mellitus in Chinese population. Endocrine 35:414-419
90. Stumvoll M, Fritsche A, Volk A, Stefan N, Madaus A, Maerker E, Teigeler A, Koch M, Machicao F, Häring H. 2001 The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. Diabetes 50: 882-885
91. Baratta R, Rossetti P, Prudente S, Barbetti F, Sudano D, Nigro A, Farina MG, Pellegrini F, Trischitta V, Frittitta L. 2008 Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes 57:3360-3364
92. Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, Ruokonen A, Ebrahim S, Shields B, Zeggini E, Weedon MN, Lindgren CM, Lango H, Melzer D, Ferrucci L, Paolisso G, NevilleMJ,Karpe F, PalmerCN,MorrisAD, Elliott P, Jarvelin MR, Smith GD, McCarthy MI, Hattersley AT, FraylingTM. 2008 Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 57:1419-1426
93. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissén M, Isomaa B, Forsen B, Homström N, Saloranta C, Taskinen MR, Groop L, Tuomi T. 2005 Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54:166-174
94. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. 2007 What is the best predictor of future type 2 diabetes? Diabetes Care 30:1544-1548
95. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segre' AV, van Hoek M, Navarro P, et al. 2010 Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579-589
96. Nerpin E, Risérus U, Ingelsson E, Sundström J, Jobs M, Larsson A, Basu S, Arnlö v J. 2008 Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 31:1550-1555
97. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. 2004 The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Int Med 140:167-174
98. De Cosmo S, Prudente S, Andreozzi F, Morini E, Rauseo A, Scarpelli D, Zhang YY, Xu R, Perticone F, Dallapiccola B, Sesti G, Doria A, Trischitta V. 2007 Glutamine to arginine substitution at amino acid 84 of mammalian tribbles homolog TRIB3 and CKD in whites with type 2 diabetes. Am J Kidney Dis 50:688-689
99. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-MelanderM. 2008 Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40:189-197
100. Willer CJ, Sanna S, JacksonAU,Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, et al. 2008 Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169
101. IBC 50K CAD Consortium. 2011 Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet 7:e1002260
102. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, Penninx BW, Janssens AC, Wilson JF, Spector T, Martin NG, Pedersen NL, Kyvik KO, Kaprio J, Hofman A, Freimer NB, Jarvelin MR, Gyllensten U, Campbell H, Rudan I, Johansson A, Marroni F, Hayward C, Vitart V, Jonasson I, et al. 2009 Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41:47-55 Save